Wen Acquisition Corp filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the period ended June 30, 2026.
MapLight Therapeutics, Inc. filed a current report on Form 8-K on August 13, 2026, disclosing a private placement of common stock and pre-funded warrants expected to generate approximately $150.0 million in gross proceeds.
Thayer Ventures Acquisition Corporation II, a blank-check special purpose acquisition company incorporated in the Cayman Islands and listed on NASDAQ:TVAI, filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the SEC on August 13, 2026.
MapLight Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the period ended June 30, 2026.
ITHAX Acquisition Corp. III, a blank check SPAC incorporated in the Cayman Islands, filed its Form 10-Q for the quarter ended June 30, 2026 with the SEC on August 13, 2026.
REalloys Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the period ended June 30, 2026, disclosing a net loss of $143,536 thousand for the six months ended June 30, 2026.
REalloys Inc. filed a current report on August 13, 2026, disclosing the issuance of an earnings release covering its financial results for the three and six months ended June 30, 2026.
Titan Acquisition Corp filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the period ended June 30, 2026.
Celcuity Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the quarterly period ended June 30, 2026, and disclosing key operational and regulatory details for the commercial-stage biopharmaceutical company.
Pershing Square Inc. filed its Form 10-Q with the Securities and Exchange Commission on August 13, 2026, covering the quarterly period ended June 30, 2026.